MADDEN DAVID 4
4 · Dicerna Pharmaceuticals Inc · Filed Jul 20, 2017
Insider Transaction Report
Form 4
MADDEN DAVID
Director
Transactions
- Award
Director Stock Option (right to buy)
2017-07-18+33,000→ 33,000 totalExercise: $3.42Exp: 2027-07-18→ Common Stock (33,000 underlying)
Footnotes (1)
- [F1]This option vests monthly over 12 months from July 11, 2017 in substantially equal monthly installments, subject to the Reporting Person's continued service to the Issuer through each such date.